Cannabinoid-Based Topical Cream for Psoriasis Receiving Interest from Scientific Community
A cannabinoid-based topical cream to treat psoriasis is receiving interest from the global scientific and medical communities, according to the developer of the cream, One World Cannabis (OWC) Pharmaceutical Research company.
Positive preliminary clinical trial results showed that OWC’s active cannabinoid-based topical cream formulation led to a 70% improvement in a variety of inflammation clinical parameters related to psoriasis. Based on these promising results, and to increasing interest from the medical community to learn more about the cream. the company is expanding the size and scope of its clinical study.
Headquartered in Israel, OWC is a company focused on discovering, developing and commercializing new cannabis-based therapeutic products and treatments specifically designed for psoriasis and other medical conditions, including multiple myeloma, migraine headaches and fibromyalgia.